| For: | Niu ZS, Niu XJ, Wang M. Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survival. World J Hepatol 2015; 7(1): 7-27 [PMID: 25624992 DOI: 10.4254/wjh.v7.i1.7] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i1/7.htm |
| Number | Citing Articles |
| 1 |
Zhen Long Ng, Jiamin Siew, Jia Li, Guanxu Ji, Min Huang, Xiaohua Liao, Sue Yu, Yuanyuan Chew, Chin Wen Png, Yongliang Zhang, Shijun Wen, Henry Yang, Yiting Zhou, Yun Chau Long, Zhi Hong Jiang, Qiang Wu. PATZ1 (MAZR) Co-occupies Genomic Sites With p53 and Inhibits Liver Cancer Cell Proliferation via Regulating p27. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.586150
|
| 2 |
Xiaodong Wang, Dongying Chen, Bin Chen. The Long-To-Short-Axis Ratio and Multifocality are Associated With TP53 Mutation Status in Surgically Resected Hepatocellular Carcinomas. Academic Radiology 2020; 27(12) doi: 10.1016/j.acra.2018.04.021
|
| 3 |
Ganbin Qiu, Jincan Chen, Weixiong Liao, Yonghui Liu, Zhongyan Wen, Yue Zhao. Gadoxetic acid-enhanced MRI combined with T1 mapping and clinical factors to predict Ki-67 expression of hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1134646
|
| 4 |
Changwu Zhou, Xiaoyan Ni, Xin Lu, Yi Wang, Xianling Qian, Chun Yang, Mengsu Zeng. MR Features Based on LI-RADS Ver. 2018 Correlated with Cytokeratin 19 Expression in Combined Hepatocellular Carcinoma-Cholangiocarcinoma. Journal of Hepatocellular Carcinoma 2021; doi: 10.2147/JHC.S325686
|
| 5 |
Veysi Hakan YARDIMCI, Süheyla EKEMEN, Abdullah Yüksel BARUT. Safra Kesesi Adenomyomatozisi Prekanseröz Lezyon mudur? Ki-67 ve P53 Pozitif Ekspresyonunun Normal Safra Kesesi Dokusu ile Karşılaştırılması. İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi 2022; (18) doi: 10.38079/igusabder.1033234
|
| 6 |
Jia Li, Yunhui Ma, Chunyu Yang, Ganbin Qiu, Jingmu Chen, Xiaoliang Tan, Yue Zhao. Radiomics analysis of R2* maps to predict early recurrence of single hepatocellular carcinoma after hepatectomy. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1277698
|
| 7 |
Yang Wu, Tian Li, Jiucong Zhang, Xiaofeng Zheng, Xiaohui Yu. Air pollution-driven key regulators in hepatocellular carcinoma: Identification via integrated bioinformatics and network toxicology. Toxicology and Environmental Health Sciences 2026; doi: 10.1007/s13530-026-00311-0
|
| 8 |
Yu-meng Zhao, Shuang-shuang Xie, Yong-quan Yu, Zhao-xian Li, Jia-ming Qin, Zhan-dong Hu, Ya-min Zhang, Zhao-xiang Ye, Jian-hua Yan, Wen Shen. A web-based prognostic nomogram incorporating VETC-associated imaging markers for predicting postoperative recurrence in hepatocellular carcinoma. BMC Cancer 2026; 26(1) doi: 10.1186/s12885-026-15895-6
|
| 9 |
Qamar Abuhassan, Omer Qutaiba B. Allela, Radhwan Abdul Kareem, Soumya V. Menon, Priya Priyadarshini Nayak, J. Bethanney Janney, Vimal Arora, Aashna Sinha, Hayder Naji Sameer, Atheer Khdyair Hamad, Zainab H. Athab, Mohaned Adil. Liver cancer stem cells as novel diagnostic biomarkers. Clinica Chimica Acta 2026; 580 doi: 10.1016/j.cca.2025.120739
|
| 10 |
Amr Abdel-Moety, Nahed Baddour, Perihan Salem, Hesham El-Tobgy, Assem El-Shendidi. SQSTM1 Expression in Hepatocellular Carcinoma and Relation to Tumor Recurrence After Radiofrequency Ablation. Journal of Clinical and Experimental Hepatology 2022; 12(3) doi: 10.1016/j.jceh.2021.12.001
|
| 11 |
Da-Wei Sun, Lin An, Feng Wei, Lin Mu, Xiao-Ju Shi, Chuan-Lei Wang, Zheng-Wei Zhao, Teng-Fei Li, Guo-Yue Lv. Prognostic significance of parameters from pretreatment 18F-FDG PET in hepatocellular carcinoma: a meta-analysis. Abdominal Radiology 2016; 41(1) doi: 10.1007/s00261-015-0603-9
|
| 12 |
Zhiqing Mo, Hao Ding, Xiaojiao Zhou, Zisan Zeng, Liling Long. Gd-EOB-DTPA-enhanced magnetic resonance imaging may help identify patients with hepatocellular carcinoma eligible for treatment targeted at RAF1. Abdominal Radiology 2022; 47(1) doi: 10.1007/s00261-021-03325-z
|
| 13 |
Ertugrul Karabulut, Sami Akbulut, Emine Turkmen Samdanci, Ayse Nur Akatli, Ahmed Elsarawy, Zeynep Kucukakcali, Zeki Ogut, Adem Tuncer, Volkan Ince, Sezai Yilmaz. Are Ki-67 and Procalcitonin Expression Levels Useful in Predicting the Biological Behavior of Hepatocellular Carcinoma After Liver Transplantation?. Journal of Clinical Medicine 2024; 14(1) doi: 10.3390/jcm14010144
|
| 14 |
HONG-JUN LI, QI-MAN SUN, LONG-ZI LIU, JUN ZHANG, JUN HUANG, CHENG-HONG WANG, RUI DING, KANG SONG, ZHONG TONG. High expression of IL-9R promotes the progression of human hepatocellular carcinoma and indicates a poor clinical outcome. Oncology Reports 2015; 34(2) doi: 10.3892/or.2015.4060
|
| 15 |
Aloísio Felipe-Silva, Alda Wakamatsu, Cinthya dos Santos Cirqueira, Venâncio Avancini Ferreira Alves. Immunohistochemistry panel segregates molecular types of hepatocellular carcinoma in Brazilian autopsy cases. World Journal of Gastroenterology 2016; 22(27): 6246-6256 doi: 10.3748/wjg.v22.i27.6246
|
| 16 |
Hui Xiong, Yuan-Lin Zeng. Standard-b-Value Versus Low-b-Value Diffusion-Weighted Imaging in Hepatic Lesion Discrimination. Journal of Computer Assisted Tomography 2016; 40(3) doi: 10.1097/RCT.0000000000000377
|
| 17 |
Marie Lequoy, Christèle Desbois‐Mouthon, Dominique Wendum, Vandana Gupta, Jean‐Luc Blachon, Olivier Scatton, Sylvie Dumont, Mireille Bonnemaire, Fabien Schmidlin, Olivier Rosmorduc, Laetitia Fartoux. Somatostatin receptors in resected hepatocellular carcinoma: status and correlation with markers of poor prognosis. Histopathology 2017; 70(3) doi: 10.1111/his.13034
|
| 18 |
Haoyu Sun, Jing Xu, Mei Huang, Qiang Huang, Rui Sun, Weihua Xiao, Cheng Sun. CD200R, a co-inhibitory receptor on immune cells, predicts the prognosis of human hepatocellular carcinoma. Immunology Letters 2016; 178 doi: 10.1016/j.imlet.2016.08.009
|
| 19 |
M. A. Abdelwa, M. M. Elbedew, A. M. Amin, A. K. Tawfik. Serum Endoglin and IL-6 Levels as Complementary Diagnostic Biomarkers for Hepatocellular Carcinoma in Egyptian Liver Cirrhosis Patients. Research Journal of Immunology 2016; 10(1) doi: 10.3923/rji.2017.1.7
|
| 20 |
Xin-Xing Hu, Wen-Tao Wang, Li Yang, Zhao-Xia Yang, He-Yue Liang, Ying Ding, Yuan Ji, Meng-Su Zeng, Sheng-Xiang Rao. MR features based on LI-RADS identify cytokeratin 19 status of hepatocellular carcinomas. European Journal of Radiology 2019; 113 doi: 10.1016/j.ejrad.2019.01.036
|
| 21 |
Xin Yuan, Yize Zhang, Zujiang Yu. Expression and clinical significance of miR-3615 in hepatocellular carcinoma. Journal of International Medical Research 2021; 49(1) doi: 10.1177/0300060520981547
|